MENACTRA (Sanofi-Aventis Australia Pty Ltd)
Product name
MENACTRA
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
177 working days (255)
Active ingredients
meningococcal [groups A, C,Y and W-135] polysaccharide diphtheria toxoid conjugate vaccine)
Registration type
EOI
Indication
MENACTRA (solution for intramuscular injection) is now also indicated for active immunisation of individuals 9 months through to 55 years of age for the prevention of invasive meningococcal disease caused by N meningitides serogroups A,C,Y and W135.